Detalles de la búsqueda
1.
A Multinational Trial of Prasugrel for Sickle Cell Vaso-Occlusive Events.
N Engl J Med
; 374(7): 625-35, 2016 Feb 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-26644172
2.
Successful utilization of an electronic pain diary in a multinational phase 3 interventional study of pediatric sickle cell anemia.
Clin Trials
; 14(6): 563-571, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28743191
3.
Design of the DOVE (Determining Effects of Platelet Inhibition on Vaso-Occlusive Events) trial: A global Phase 3 double-blind, randomized, placebo-controlled, multicenter study of the efficacy and safety of prasugrel in pediatric patients with sickle cell anemia utilizing a dose titration strategy.
Pediatr Blood Cancer
; 63(2): 299-305, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26402148
4.
Prasugrel in children with sickle cell disease: pharmacokinetic and pharmacodynamic data from an open-label, adaptive-design, dose-ranging study.
J Pediatr Hematol Oncol
; 37(1): 1-9, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25493452
5.
Novel findings from the multinational DOVE study on geographic and age-related differences in pain perception and analgesic usage in children with sickle cell anaemia.
Br J Haematol
; 184(6): 1058-1061, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29676449
6.
Geographic Differences in Phenotype and Treatment of Children with Sickle Cell Anemia from the Multinational DOVE Study.
J Clin Med
; 8(11)2019 Nov 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-31744266
7.
Real-time dose adjustment using point-of-care platelet reactivity testing in a double-blind study of prasugrel in children with sickle cell anaemia.
Thromb Haemost
; 117(3): 580-588, 2017 02 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-27929203
8.
A double-blind, randomized, multicenter phase 2 study of prasugrel versus placebo in adult patients with sickle cell disease.
J Hematol Oncol
; 6: 17, 2013 Feb 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-23414938
Resultados
1 -
8
de 8
1
Próxima >
>>